Patents and Publications

09Feb 2026

Discovery of Anti-SARS-CoV-2 XBB.1.5 and JN.1 Variant-Specific Monoclonal Single-Domain Antibodies from a Synthetic Library

Authors Isamu Tsuji1, Kumiko Okada2, Benjamin Kroppen3, Tetsufumi Katta2, Kaori Yamamura2, Takeshi Nishihama2, Ayako Miura1, Hansjörg Götzke3, Eric ...
18Dec 2025

Anti-hepsin Antibodies and Uses Thereof

Inventors Blake Johnson, Timothy O’brien Assignees Navaux Inc. Abstract The present application discloses methods of using anti-hepsin antibodies to ...
25Nov 2025

Human Capital Is the Most Valuable

Authors Renato Zenobi Organizations ETH Zürich, Zürich, Switzerland Abstract In early October 2025, I attended the farewell party for ...
25Nov 2025

Discovery and Characterization of Two anti-PD-1 Antibodies with a Unique Binding Mechanism to human PD-1

Authors Keyla María Gómez Castellanoa,b, Alejandra Montes Lunaa,b, Gregorio de Jesús Carballo Uicaba,b, Frida ...
09Oct 2025

FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, Designed for Optimal CD137 Engagement Resulting in Potent Conditional T-Cell Activity

Authors Matthew A. Lakins1, Christel Séguy Veyssier2, Jose Munoz-Olaya1, Emma Goodman1, Robert Hughes1, James J Day1, Quincy Kaka1, Jennifer ...
02Oct 2025

Trogocytosis-inducing Bispecific Molecules and Methods of Use

Inventors Carolyn R. Bertozzi, Muthukumar Ramanathan, Nicholas Till Assignees Leland Stanford Junior University Abstract Provided are soluble bispecific molecules. In ...
11Sep 2025

Integrating Multiple MS Techniques for in-Depth Antibody Glycosylation Analysis: Revealing Glycosylation-Dependent Structural and Functional Properties

Authors Yuye Zhou1,2, Sophia Schedin Weiss3, Congrui Tan1, Philipp Bittner1, Julian A. Harrison4, Lars Tjernberg3, Asa Emmer2, Renato Zenobi1 Organizations ...
text
Talk to Our Scientists

Our team is available to answer any of your questions about our products and services